SECsense Logo

Aptose Biosciences Inc. Form 8-K: Key Corporate Event Insights

$APTO
Form 8-K
Filed on: 2025-02-13
Source
Aptose Biosciences Inc. Form 8-K: Key Corporate Event Insights

Based on the provided section of the financial report, here are the key pieces of information and insights:

  1. Filing Type: This report is a Form 8-K, which is used to report unscheduled material events or corporate changes that are of importance to shareholders.
  2. Entity Information:
  • Company Name: Aptose Biosciences Inc.
  • CIK: 0000882361 - This is the Central Index Key number for the company, which is a unique identifier used by the SEC.
  • IRS Employer Identification Number (EIN): 98-1136802.
  • Location: 66 Wellington Street West, Suite 5300, TD Bank Tower, Box 48, Toronto, ON M5K 1E6.
  • Contact Number: 310-849-8060.
  1. Event Date: The event reported in this 8-K filing occurred on February 13, 2025.
  2. Share Information:
  • Security Type: Common Shares with no par value.
  • Ticker Symbol: APTO, which is listed on NASDAQ.
  • Unit of Measure: Financials are reported in USD (United States Dollar) and shares.
  1. Reporting Context:
  • The reporting period starts and ends on the same date: February 13, 2025, indicating that this may be a specific event or change rather than a period of financial performance.

Insights:

  • The filing is likely related to a significant event that occurred on the specified date, which may affect the company’s stock or operations.
  • As a biotechnology company, Aptose Biosciences Inc. could be announcing developments such as clinical trial results, partnerships, or regulatory filings, which are important for investors and stakeholders.
  • The report falls under the standard regulatory framework of the SEC, showing compliance with disclosure requirements.

This information is crucial for investors and analysts looking to understand recent developments affecting Aptose Biosciences Inc. and to assess potential impacts on share performance and company strategy.